Patterns of initial management of node-negative breast cancer in two Canadian provinces
Goel V, Olivotto I, Hislop TG, Sawka C, Coldman A, Holowaty EJ. CMAJ. 1997; 156(1):25-35.
Publications
Development of an instrument to measure cancer screening knowledge, attitudes and behaviours
Kindree T, Ashbury FD, Goel V, Levy I, Lipskie T, Futcher R. Chronic Dis Can. 1997; 18(4):168-75.
Compliance with practice guidelines for node-negative breast cancer
Olivotto IA, Coldman AJ, Hislop TG, Trevisan CH, Kula J, Goel V, Sawka C. J Clin Oncol. 1997; 15(1):216-22.
The association between population-based treatment guidelines and adjuvant therapy for node-negative breast cancer
Sawka C, Olivotto I, Coldman A, Goel V, Holowaty E, Hislop TG. Br J Cancer. 1997; 75(10):1534-42.
Development of a measure of physical function for patients with bone and soft tissue sarcoma
Davis AM, Wright JG, Williams JI, Bombardier C, Griffin A, Bell RS. Qual Life Res. 1996; 5(5):508-16.
Orchidectomy and hormonal therapy of prostate cancer
To T, Iscoe N, Klotz L, Naylor CD. Can J Urol. 1995; 2(1):109-15.
Factors associated with cervical cancer screening: results from the Ontario Health Survey
Goel V. Can J Public Health. 1994; 85(2):125-7.
Perceived informational needs of breast cancer patients receiving radiation therapy after excisional biopsy and axillary node dissection
Harrison-Woermke DE, Graydon JE. Cancer Nurs. 1993; 16(6):449-55.